Skip to content

MRA/fMRI Study of Spontaneous Migraine

Functional MRI and MR Angiography Used in Spontaneous Migraine

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01471314
Enrollment
Unknown
Registered
2011-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2012-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache Versus Non-headache Day

Brief summary

The purpose of this study is to examine migraineurs during spontaneous migraine attacks without aura, using high resolution magnetic resonance imaging (MRI), to study following: * Changes in resting state blood-oxygenation-level-dependent-signal (BOLD-signal) using functional MRI (fMRI). * Changes in circumferences of intra- and extracranial arteries using MR-angiography (MRA). * Changes in regional and global cerebral blood flow (CBF) using the arterial spin labeling (ASL) method. Moreover to perform diffusion tensor imaging (DTI) scans during spontaneous migraine attacks. The migraine specific drug sumatriptan will be given to relieve pain and the effect will be registered using MRA and fMRI if possible.

Interventions

BEHAVIORALHeadache day versus non-headache day

Sponsors

Leiden University Medical Center
CollaboratorOTHER
Glostrup University Hospital, Copenhagen
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Migraine without aura according to IHS criteria.

Exclusion criteria

* Other primary headaches. * Tension-type headache more than 5 days/month. * Use of anti-pain medication before the scanning on the examination day. * Pregnant or nursing women. * Contraindication for MR scan. * Anamnestic or clinical signs of cardiovascular or cerebrovascular disease, unregulated psychiatric disease or drug misuse. * Other clinical conditions assessed by the examining doctor.

Countries

Denmark

Contacts

Primary ContactFaisal Amin, MD, PhD student
famoam01@regionh.dk+4538633066

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026